These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 1802548)

  • 1. Interference by anti-C5a monoclonal antibodies with the binding of C5a to cellular receptors and the induction of enzyme release from granulocytes.
    Bergh K; Iversen OJ
    Complement Inflamm; 1991; 8(5-6):294-302. PubMed ID: 1802548
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epitope mapping of a C5a neutralizing mAb using a combined approach of phage display, synthetic peptides and site-directed mutagenesis.
    Kola A; Baensch M; Bautsch W; Hennecke M; Klos A; Casaretto M; Köhl J
    Immunotechnology; 1996 Jun; 2(2):115-26. PubMed ID: 9373320
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma clearance of the human C5a anaphylatoxin by binding to leucocyte C5a receptors.
    Oppermann M; Götze O
    Immunology; 1994 Aug; 82(4):516-21. PubMed ID: 7835913
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Probing the human receptor for C5a anaphylatoxin with site-directed antibodies. Identification of a potential ligand binding site on the NH2-terminal domain.
    Oppermann M; Raedt U; Hebell T; Schmidt B; Zimmermann B; Götze O
    J Immunol; 1993 Oct; 151(7):3785-94. PubMed ID: 8376805
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection of C5a receptors on human eosinophils and inhibition of eosinophil effector functions by anti-C5a receptor (CD88) antibodies.
    Elsner J; Oppermann M; Kapp A
    Eur J Immunol; 1996 Jul; 26(7):1560-4. PubMed ID: 8766561
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pre-neutralization of C5a-mediated effects by the monoclonal antibody 137-26 reacting with the C5a moiety of native C5 without preventing C5 cleavage.
    Fung M; Lu M; Fure H; Sun W; Sun C; Shi NY; Dou Y; Su J; Swanson X; Mollnes TE
    Clin Exp Immunol; 2003 Aug; 133(2):160-9. PubMed ID: 12869020
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of an antigenic epitope and receptor binding domain of human C5a.
    Johnson RJ; Tamerius JD; Chenoweth DE
    J Immunol; 1987 Jun; 138(11):3856-62. PubMed ID: 2438329
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of anti-C5a antibodies on human polymorphonuclear leukocyte function: chemotaxis, chemiluminescence, and lysosomal enzyme release.
    Hatherill JR; Stephens KE; Nagao K; Ishizaka A; Wilmarth L; Wang JC; Deinhart T; Larrick JW; Raffin TA
    J Biol Response Mod; 1989 Dec; 8(6):614-24. PubMed ID: 2600603
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The human mast cell line HMC-1 expresses C5a receptors and responds to C5a but not to C5a(desArg).
    Werfel T; Oppermann M; Butterfield JH; Begemann G; Elsner J; Götze O; Zwirner J
    Scand J Immunol; 1996 Jul; 44(1):30-6. PubMed ID: 8693289
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Specific detection by flow cytometry of histidine-tagged ligands bound to their receptors using a tag-specific monoclonal antibody.
    Wilken HC; Rogge S; Götze O; Werfel T; Zwirner J
    J Immunol Methods; 1999 Jun; 226(1-2):139-45. PubMed ID: 10410979
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biologically active conformer of the effector region of human C5a and modulatory effects of N-terminal receptor binding determinants on activity.
    Finch AM; Vogen SM; Sherman SA; Kirnarsky L; Taylor SM; Sanderson SD
    J Med Chem; 1997 Mar; 40(6):877-84. PubMed ID: 9083476
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of the tissue distribution of the rat C5a receptor and inhibition of C5a-mediated effects through the use of two MoAbs.
    Rothermel E; Götze O; Zahn S; Schlaf G
    Scand J Immunol; 2000 Oct; 52(4):401-10. PubMed ID: 11013012
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Production of monoclonal antibodies against the human anaphylatoxin C5a des Arg and their application in the neoepitope-specific sandwich-ELISA for the quantification of C5a des Arg in plasma.
    Bergh K; Iversen OJ
    J Immunol Methods; 1992 Jul; 152(1):79-87. PubMed ID: 1379278
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Site-specific mutagenesis of residues in the human C5a anaphylatoxin which are involved in possible interaction with the C5a receptor.
    Bubeck P; Grötzinger J; Winkler M; Köhl J; Wollmer A; Klos A; Bautsch W
    Eur J Biochem; 1994 Feb; 219(3):897-904. PubMed ID: 8112341
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Functional Analysis of a Novel Complement C5a Receptor 1-Blocking Monoclonal Antibody.
    Cyranka L; Mariegaard I; Skjødt MO; Bayarri-Olmos R; Mollnes TE; Garred P; Rosbjerg A
    J Innate Immun; 2023; 15(1):836-849. PubMed ID: 37952515
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential expression of the C5a receptor on the main cell types of rat liver as demonstrated with a novel monoclonal antibody and by C5a anaphylatoxin-induced Ca2+ release.
    Schlaf G; Schieferdecker HL; Rothermel E; Jungermann K; Götze O
    Lab Invest; 1999 Oct; 79(10):1287-97. PubMed ID: 10532591
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Measurement of complement activation in rabbit plasma or serum using monoclonal antibodies against C5a.
    Bergh K; Iversen OJ
    Scand J Immunol; 1989 Mar; 29(3):333-41. PubMed ID: 2470136
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Demonstration of specific C5a receptor on intact human polymorphonuclear leukocytes.
    Chenoweth DE; Hugli TE
    Proc Natl Acad Sci U S A; 1978 Aug; 75(8):3943-7. PubMed ID: 279010
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of C5a receptor by monoclonal antibody.
    Watanabe H; Kuraya M; Kasukawa R; Yanagisawa H; Yanagisawa M; Fujita T
    J Immunol Methods; 1995 Sep; 185(1):19-29. PubMed ID: 7665898
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A sensitive enzyme immunoassay for the quantitation of human C5a/C5a(desArg) anaphylatoxin using a monoclonal antibody with specificity for a neoepitope.
    Oppermann M; Schulze M; Götze O
    Complement Inflamm; 1991; 8(1):13-24. PubMed ID: 1710957
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.